KB Securities

Total investments

104

Average round size

8M

Portfolio companies

92

Lead investments

3

Follow on index

0.12

Exits

17

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceHealth CareAppsBig DataManufacturingMedicalPharmaceutical

Investments analytics

Analytics

Total investments
104
Lead investments
3
Exits
17
Follow on index
0.12
Investments by industry
  • Software (21)
  • Information Technology (19)
  • Health Care (15)
  • Biotechnology (13)
  • Manufacturing (11)
  • Show 120 more
Investments by region
  • South Korea (82)
  • Singapore (1)
  • United States (13)
  • Japan (1)
  • China (3)
  • Show 1 more
Peak activity year
2021
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
13
Avg. valuation at time of investment
80M
Group Appearance index
0.72
Avg. company exit year
12
Avg. multiplicator
1.14

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Onegene Biotechnology 18 Feb 2021 Biotechnology, Life Science, Therapeutics Early Stage Venture 12M Gyeonggi-do, Seongnam-si, South Korea
SSEM 29 Apr 2024 FinTech, Information Technology, Apps Early Stage Venture 4M Seoul-t'ukpyolsi, Yeoksamdong, South Korea

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.